Molecular pathways in the formation of gliomas

Glia
A von DeimlingO D Wiestler

Abstract

The past few years have seen remarkable progress in understanding the molecular genetic basis of glioma formation. Affected oncogenes and tumor suppressor genes have been identified and putative tumor suppressor loci have been mapped. These studies have illustrated distinct molecular pathways for different glial neoplasms. We summarize the findings of an ongoing study initiated to characterize human gliomas on a molecular basis. The data are compiled from 150 astrocytic, oligodendroglial, and mixed gliomas that were assessed for genomic alterations characteristic of these neoplasms, i.e., loss of portions of chromosomes 1p, 9p, 10, 17p, 17q, and 19q, mutations of the p53 tumor suppressor gene, and amplification of the EGF receptor (EGFR) gene. Our findings support the hypothesis that distinct genetic pathways result in the formation of astrocytic and oligodendroglial neoplasms of different malignancy grades, and that glioblastoma multiforme may be subdivided into genetically distinct subsets. Such findings may not only lead to a better understanding of neoplastic transformation in glial cells, but may also have a major impact on clinical neuro-oncology.

References

Jan 1, 1992·Journal of Neuropathology and Experimental Neurology·M R HurttJ Locker
Jul 5, 1991·Science·M HollsteinC C Harris
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C D JamesW K Cavenee
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M el-AzouziK Panagopoulos
May 1, 1988·Journal of Neuropathology and Experimental Neurology·S H BignerD D Bigner
Apr 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Aug 1, 1984·Ophthalmology·R A LewisR P Whitford
Dec 1, 1993·Neuropathology and Applied Neurobiology·A von DeimlingO D Wiestler
Apr 1, 1995·Brain Pathology·A von DeimlingA G Menon
Jan 1, 1995·Journal of Neuropathology and Experimental Neurology·J A KrausA von Deimling
Nov 1, 1994·Annals of Neurology·J W HensonD N Louis
Sep 1, 1993·Journal of Neuropathology and Experimental Neurology·D N LouisA von Deimling
Jan 1, 1993·Acta Neuropathologica·A von DeimlingB R Seizinger
Jun 1, 1994·International Journal of Cancer. Journal International Du Cancer·A von DeimlingO D Wiestler
Mar 1, 1993·Indian Journal of Pediatrics·B M Ansari
Jan 1, 1993·Brain Pathology·A von DeimlingD N Louis

❮ Previous
Next ❯

Citations

Jan 4, 1998·Seminars in Surgical Oncology·A Sehgal
Jan 1, 1997·Acta neurochirurgica·W T CouldwellC B Stillerman
Feb 9, 2005·Brain Tumor Pathology·Chitra SarkarVeer Singh Mehta
Jun 19, 2013·Der Nervenarzt·M PlattenW Wick
Jan 27, 2005·Journal of Cancer Research and Clinical Oncology·R MartinezG Schackert
Sep 1, 2006·Wiener medizinische Wochenschrift·Markus HuttererGuenther Stockhammer
Dec 2, 2008·Journal of Neuro-oncology·Mia CarapanceaAnica Dricu
Nov 11, 2010·Journal of Neuro-oncology·M M Lino, A Merlo
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Kaveh Asadi-Moghaddam, E Antonio Chiocca
Jul 17, 1998·The American Journal of Pathology·I F Newsham
May 9, 2002·Cancer Genetics and Cytogenetics·Xiao Lu YinHo Keung Ng
Nov 26, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·M M ValterT Pietsch
Apr 2, 2010·ACS Applied Materials & Interfaces·Aaron M LoweNicholas L Abbott
Aug 26, 2006·Nature Clinical Practice. Neurology·Judith A SchwartzbaumMargaret Wrensch
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·A RencicD Andrews
Feb 13, 2010·Neuro-oncology·Caroline HouillierJean-Yves Delattre
Jun 6, 2003·The Cancer Journal·Kenneth D AldapeMargaret Wrensch
May 20, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A M StarkH M Mehdorn
Jul 5, 2006·Neurosurgical Focus·A Sehgal, M S Berger
Jan 10, 2006·Neurosurgical Focus·Margaret WrenschKenneth D Aldape
Sep 2, 1999·Journal of Neurosurgery·M A VogelbaumK M Rich
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·D M Li, H Sun
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·F B FurnariW K Cavenee
Jan 1, 1997·Acta neurochirurgica·E Van de Kelft

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.